SlideShare a Scribd company logo
Metrological Experiments in Biomarker Development   (Mass Spectrometry—Statistical Issues) Walter Liggett  Statistical Engineering Division Peter Barker Biotechnology Division National Institute of Standards and Technology
Biomarker (Clinical Pharmacology & Therapeutics, 2001) A characteristic that is  objectively measured  and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Two parts of a biomarker Execution of measurement protocol Interpretation of measured response
Metrology Development and evaluation of a measurement protocol, the first part of a biomarker Diverse lessons learned from varied applications Focus on general purpose protocols which may be adequate for a particular purpose The use of metrology in biomarker development is the subject of this talk
Metrological Experiments Experimental units (specimens) Knowledge of their characteristics Relation to unknowns of future interest Response Univariate—interval-scale variable Multivariate/Functional Protocol parameters—parameter design Cost of experimental runs—high throughput?
Outline Alternative statistical formulations Classification based on cases and controls Measurement of an interval-scale variable Aspects of protocol development Property of interest Realization of protocol Multivariate and functional measurements
Statistics for Classification Assume gold standard for disease status Evaluate marker on training data Sensitivity—true positive rate Specificity—1 – false positive rate Continuous test result—ROC curves Multivariate test result—classification, discriminant analysis
Pepe, et al., J. National Cancer Institute, 2001 Specimen Selection Wide spectrum of tumor and non-tumor tissue Serum from cases and controls in a target screening population Apparently healthy subjects monitored for development of cancer Cohort from a population that might be targeted Subjects randomly selected from populations in which the screening program is likely
Thinking Outside the Box Bottom line is prediction of disease status Definitive gold standard may not be available Including laboratory sources of error in training data is a problem There are metrological experiments that do not require a gold standard
The Role of Science Given valid training data, statisticians can proceed without scientific knowledge In the classification approach, scientific thought must go into specimen selection In the metrological approach, focus is on a property to be measured Scientific thought must go into the relation of the metrological property to biomarker goals
Statistics for Metrology Focus (as best one can) on the property to be measured, an interval- or ratio-scale variable Specify a baseline measurement protocol Experiment with realizations of alternative protocols Optimize repeatability (at least) and then ask if the measurement protocol is adequate for the purpose
Framework of Metrology Relation between property and protocol obtained scientifically or through realization Metrology explores faithfulness of realization before adequacy for the purpose Property Realization Protocol
Some Metrological Experiments Protocol development through classes of units known to differ in the property of interest Protocols linked to a scientific definition of the property of interest in such a way that all sources of error can be assessed (definitive methods) Sets of protocols that measure the same property but are based on different scientific principles (independent methods)
Aspects of Performance Repeatability All manner of reproducibility Operator, equipment Inter-laboratory Noise factors, effect of sample matrix Calibration Measurement assurance Uncertainty components, type A and type B uncertainties
Experimental Units (Reference Materials) Homogeneity (solution versus particles) Quantity (cost) Adaptable to high-throughput experiments Known value of the property of interest Classes with different values of the property of interest
From Univariate to Functional Carryover has been done for classification Extending measurement performance concepts to multivariate and functional responses is still a challenge Chemometrics is the key word for much of the literature in this area
Functional Principal Components Analysis (Ramsay and Silverman) Metrologists like to look at the spread of a batch of measurements (outliers, more than one mode) For functional measurements, functional PCA provides a way to look at the spread Consider results of functional PCA on Petricoin’s Lancet…/Normal Healthy (SPLUS, Ramsay’s software) Main purpose is to illustrate metrological thinking
 
 
 
 
Conclusion Producing large data sets has become easier except perhaps for selecting individuals with a particular disease status With scientific and statistical reasoning, the advances in experimentation technology can be used to speed biomarker development Statisticians have a role in formulating overall experimental strategy, allocating effort among different approaches

More Related Content

PPTX
Research Methods for Computational Statistics
PPTX
Analyzing data
DOCX
Flow of ordinary research process
PDF
Analytical instrumentation 2015 contents
PPT
Data Extraction Quiz
PPTX
.Analyzing data
PDF
9-Meta Analysis/ Systematic Review
PPT
Systematic review ppt
Research Methods for Computational Statistics
Analyzing data
Flow of ordinary research process
Analytical instrumentation 2015 contents
Data Extraction Quiz
.Analyzing data
9-Meta Analysis/ Systematic Review
Systematic review ppt

What's hot (20)

PPT
Assessing Applicability Quiz
DOC
2010 FDA/Industry Statistics Workshop
PPT
Quantitative Synthesis I Quiz
PPT
Quantitative Synthesis II
PPT
Data Extraction
PDF
ATPI Dissertation Proposal Rubric 2013
PPTX
Seminaar on meta analysis
PDF
4th Annual Advancing the Pace of Chemical Risk Assessment
PDF
Search in Medical Text
PPT
When to Select Observational Studies Quiz
PPT
Brief overview on meta analysis
PDF
How to handle discrepancies while you collect data for systemic review – pubrica
PPTX
Systematic review and meta analysis
PPT
Sampling f2011
PPTX
Systematic review
PDF
Defining and formalizing radiology and PACS performance
PPTX
META ANALYSIS
PPTX
Analytical cchemistry
PPTX
Meta analysis
PPTX
Materials and Methods
Assessing Applicability Quiz
2010 FDA/Industry Statistics Workshop
Quantitative Synthesis I Quiz
Quantitative Synthesis II
Data Extraction
ATPI Dissertation Proposal Rubric 2013
Seminaar on meta analysis
4th Annual Advancing the Pace of Chemical Risk Assessment
Search in Medical Text
When to Select Observational Studies Quiz
Brief overview on meta analysis
How to handle discrepancies while you collect data for systemic review – pubrica
Systematic review and meta analysis
Sampling f2011
Systematic review
Defining and formalizing radiology and PACS performance
META ANALYSIS
Analytical cchemistry
Meta analysis
Materials and Methods
Ad

Similar to Metrological experiments in biomarker development (mass spectrometry statistical issues) (20)

PPT
Multiplex
PDF
Methodology
PPTX
Systematic review of master protocols
PDF
Harmonization of Laboratory Testing, 08 04-2017
PPT
Meta-analysis _systematic rev pharmD.ppt
PPT
THE CONCEPT OF TRACEABILITY IN LABORATORY MEDICINE - A TOOL FOR STANDARDISATION
PPTX
5-Scientific Approach to Validation.pptx
PPTX
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
PPTX
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
PPTX
Lect4 research methodology
PPTX
SHE, Quality, and Ethics in Medical Laboratories - PCLP
PPTX
Ontologies for Semantic Normalization of Immunological Data
PPT
Feb 2009: my University of Wisconsin colloquim presentation
PPTX
1. Introduction to Analytical Instrumentation (1).pptx
PPTX
Meta analysis techniques in epidemiology
PDF
An illustrated guide to the methods of meta analysi
PDF
演講-Meta analysis in medical research-張偉豪
PPTX
Living evidence 3
PPTX
Data Extraction & Synthesis by zahida kusor
PDF
Research_Methodology_&_Biostatistics_Question_Bank.pdf
Multiplex
Methodology
Systematic review of master protocols
Harmonization of Laboratory Testing, 08 04-2017
Meta-analysis _systematic rev pharmD.ppt
THE CONCEPT OF TRACEABILITY IN LABORATORY MEDICINE - A TOOL FOR STANDARDISATION
5-Scientific Approach to Validation.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Lect4 research methodology
SHE, Quality, and Ethics in Medical Laboratories - PCLP
Ontologies for Semantic Normalization of Immunological Data
Feb 2009: my University of Wisconsin colloquim presentation
1. Introduction to Analytical Instrumentation (1).pptx
Meta analysis techniques in epidemiology
An illustrated guide to the methods of meta analysi
演講-Meta analysis in medical research-張偉豪
Living evidence 3
Data Extraction & Synthesis by zahida kusor
Research_Methodology_&_Biostatistics_Question_Bank.pdf
Ad

More from National Institute of Biologics (20)

PDF
Waters protein therapeutics application proctocols
PDF
Potential aggregation prone regions in biotherapeutics
DOCX
How the biologics landscape is evolving
PDF
Evaluation of antibody drugs quality safety
PDF
Approved m abs_feb_2015
PDF
Translating next generation sequencing to practice
PDF
From biomarkers to diagnostics –the road to success
PDF
Defining your-target-product-profile in-vitro-diagnostic-products
PDF
Accelerating development and approval of targeted cancer therapies
PDF
Canonical structures for the hypervariable regions of immunoglobulins
PDF
Canonical correlation
PDF
Development trends for human monoclonal antibody therapeutics
PDF
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
PDF
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
PDF
Therapeutic antibodies for autoimmunity and inflammation
PDF
Introduction to current and future protein therapeutics - a protein engineeri...
PDF
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...
PDF
Intended use of reference products & who international standards or reference...
PDF
How dissimilarly similar are biosimilars
PDF
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...
Waters protein therapeutics application proctocols
Potential aggregation prone regions in biotherapeutics
How the biologics landscape is evolving
Evaluation of antibody drugs quality safety
Approved m abs_feb_2015
Translating next generation sequencing to practice
From biomarkers to diagnostics –the road to success
Defining your-target-product-profile in-vitro-diagnostic-products
Accelerating development and approval of targeted cancer therapies
Canonical structures for the hypervariable regions of immunoglobulins
Canonical correlation
Development trends for human monoclonal antibody therapeutics
Therapeutic fc fusion proteins and peptides as successful alternatives to ant...
Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...
Therapeutic antibodies for autoimmunity and inflammation
Introduction to current and future protein therapeutics - a protein engineeri...
Pharmaceutical monoclonal antibodies production - guidelines to cell engine...
Intended use of reference products & who international standards or reference...
How dissimilarly similar are biosimilars
Evaluation of similar biotherapeutic products (SBP's) scientific principles ...

Recently uploaded (20)

PPTX
2 neonat neotnatology dr hussein neonatologist
PPTX
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
PPTX
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
PPTX
vertigo topics for undergraduate ,mbbs/md/fcps
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPTX
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
PDF
Transcultural that can help you someday.
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPTX
antibiotics rational use of antibiotics.pptx
PPTX
ONCOLOGY Principles of Radiotherapy.pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
PPTX
regulatory aspects for Bulk manufacturing
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPTX
Post Op complications in general surgery
PPTX
Morphology of Bacterial Cell for bsc sud
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
Cardiovascular - antihypertensive medical backgrounds
2 neonat neotnatology dr hussein neonatologist
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
NRPchitwan6ab2802f9.pptxnepalindiaindiaindiapakistan
vertigo topics for undergraduate ,mbbs/md/fcps
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
Transcultural that can help you someday.
neurology Member of Royal College of Physicians (MRCP).ppt
شيت_عطا_0000000000000000000000000000.pdf
CHEM421 - Biochemistry (Chapter 1 - Introduction)
antibiotics rational use of antibiotics.pptx
ONCOLOGY Principles of Radiotherapy.pptx
Reading between the Rings: Imaging in Brain Infections
regulatory aspects for Bulk manufacturing
PEADIATRICS NOTES.docx lecture notes for medical students
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Post Op complications in general surgery
Morphology of Bacterial Cell for bsc sud
surgery guide for USMLE step 2-part 1.pptx
Cardiovascular - antihypertensive medical backgrounds

Metrological experiments in biomarker development (mass spectrometry statistical issues)

  • 1. Metrological Experiments in Biomarker Development (Mass Spectrometry—Statistical Issues) Walter Liggett Statistical Engineering Division Peter Barker Biotechnology Division National Institute of Standards and Technology
  • 2. Biomarker (Clinical Pharmacology & Therapeutics, 2001) A characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Two parts of a biomarker Execution of measurement protocol Interpretation of measured response
  • 3. Metrology Development and evaluation of a measurement protocol, the first part of a biomarker Diverse lessons learned from varied applications Focus on general purpose protocols which may be adequate for a particular purpose The use of metrology in biomarker development is the subject of this talk
  • 4. Metrological Experiments Experimental units (specimens) Knowledge of their characteristics Relation to unknowns of future interest Response Univariate—interval-scale variable Multivariate/Functional Protocol parameters—parameter design Cost of experimental runs—high throughput?
  • 5. Outline Alternative statistical formulations Classification based on cases and controls Measurement of an interval-scale variable Aspects of protocol development Property of interest Realization of protocol Multivariate and functional measurements
  • 6. Statistics for Classification Assume gold standard for disease status Evaluate marker on training data Sensitivity—true positive rate Specificity—1 – false positive rate Continuous test result—ROC curves Multivariate test result—classification, discriminant analysis
  • 7. Pepe, et al., J. National Cancer Institute, 2001 Specimen Selection Wide spectrum of tumor and non-tumor tissue Serum from cases and controls in a target screening population Apparently healthy subjects monitored for development of cancer Cohort from a population that might be targeted Subjects randomly selected from populations in which the screening program is likely
  • 8. Thinking Outside the Box Bottom line is prediction of disease status Definitive gold standard may not be available Including laboratory sources of error in training data is a problem There are metrological experiments that do not require a gold standard
  • 9. The Role of Science Given valid training data, statisticians can proceed without scientific knowledge In the classification approach, scientific thought must go into specimen selection In the metrological approach, focus is on a property to be measured Scientific thought must go into the relation of the metrological property to biomarker goals
  • 10. Statistics for Metrology Focus (as best one can) on the property to be measured, an interval- or ratio-scale variable Specify a baseline measurement protocol Experiment with realizations of alternative protocols Optimize repeatability (at least) and then ask if the measurement protocol is adequate for the purpose
  • 11. Framework of Metrology Relation between property and protocol obtained scientifically or through realization Metrology explores faithfulness of realization before adequacy for the purpose Property Realization Protocol
  • 12. Some Metrological Experiments Protocol development through classes of units known to differ in the property of interest Protocols linked to a scientific definition of the property of interest in such a way that all sources of error can be assessed (definitive methods) Sets of protocols that measure the same property but are based on different scientific principles (independent methods)
  • 13. Aspects of Performance Repeatability All manner of reproducibility Operator, equipment Inter-laboratory Noise factors, effect of sample matrix Calibration Measurement assurance Uncertainty components, type A and type B uncertainties
  • 14. Experimental Units (Reference Materials) Homogeneity (solution versus particles) Quantity (cost) Adaptable to high-throughput experiments Known value of the property of interest Classes with different values of the property of interest
  • 15. From Univariate to Functional Carryover has been done for classification Extending measurement performance concepts to multivariate and functional responses is still a challenge Chemometrics is the key word for much of the literature in this area
  • 16. Functional Principal Components Analysis (Ramsay and Silverman) Metrologists like to look at the spread of a batch of measurements (outliers, more than one mode) For functional measurements, functional PCA provides a way to look at the spread Consider results of functional PCA on Petricoin’s Lancet…/Normal Healthy (SPLUS, Ramsay’s software) Main purpose is to illustrate metrological thinking
  • 17.  
  • 18.  
  • 19.  
  • 20.  
  • 21. Conclusion Producing large data sets has become easier except perhaps for selecting individuals with a particular disease status With scientific and statistical reasoning, the advances in experimentation technology can be used to speed biomarker development Statisticians have a role in formulating overall experimental strategy, allocating effort among different approaches